Kenchaiah Satish, Gaziano J Michael, Vasan Ramachandran S
The National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, MA 01702, USA.
Med Clin North Am. 2004 Sep;88(5):1273-94. doi: 10.1016/j.mcna.2004.04.011.
Obesity has reached epidemic proportions in the United States and worldwide. Heart failure (HF) is also a major public health problem, which, despite therapeutic advances, is associated with substantial mortality. The adverse impact of obesity on the cardiovascular system is being increasingly recognized, and includes a hyperdynamic circulation, subclinical cardiac structural and functional changes, and overt HF. At the same time, the possible protective effect of obesity in patients with established HF has been emphasized in recent studies. This article reviews evidence from epidemiologic studies evaluating the impact of overweight and obesity on the risk of HF, appraises published data on the prognostic significance of overweight and obesity after the onset of HF, describes the potential mechanisms underlying these associations,speculates on the clinical implications of current evidence, and suggests directions for future research.
肥胖在美国及全球范围内已呈流行态势。心力衰竭(HF)也是一个重大的公共卫生问题,尽管治疗取得了进展,但仍伴有相当高的死亡率。肥胖对心血管系统的不利影响日益受到认可,包括高动力循环、亚临床心脏结构和功能改变以及显性心力衰竭。与此同时,近期研究强调了肥胖在已确诊心力衰竭患者中可能具有的保护作用。本文回顾了流行病学研究的证据,评估超重和肥胖对心力衰竭风险的影响,分析已发表的关于心力衰竭发病后超重和肥胖预后意义的数据,描述这些关联背后的潜在机制,推测当前证据的临床意义,并提出未来研究的方向。